Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 06, 2023

BUY
$3.14 - $11.2 $552 - $1,971
176 Added 1.39%
12,864 $50,000
Q2 2023

Aug 01, 2023

BUY
$8.45 - $12.48 $19,020 - $28,092
2,251 Added 21.57%
12,688 $128,000
Q1 2023

Apr 27, 2023

BUY
$9.21 - $14.98 $2,624 - $4,269
285 Added 2.81%
10,437 $106,000
Q4 2022

Feb 07, 2023

BUY
$8.57 - $17.0 $87,002 - $172,584
10,152 New
10,152 $95,000

Others Institutions Holding TSVT

About 2seventy bio, Inc.


  • Ticker TSVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,873,600
  • Market Cap $150M
  • Description
  • 2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...
More about TSVT
Track This Portfolio

Track Arizona State Retirement System Portfolio

Follow Arizona State Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.